Skip to main content
. 2020 Sep 11;5:15. doi: 10.1038/s41536-020-00100-4

Fig. 5. Usage of pluripotent stem cell types (hESC and iPSC) dependent on geographic distribution and study design.

Fig. 5

a Distribution of all clinical trials and interventional and observational trials respectively, dependent on the usage of hESC or hiPSC. b Choropleth map presenting the geographic distribution of all clinical trials involving hESCs. c Choropleth map presenting the geographic distribution of all clinical trials involving hiPSCs.